T1	PrimaryOutcome 60 83	rate of hospitalization
T2	SecondaryOutcome 109 177	clinical improvements (e.g., resolution of fever, cough and dyspnea)
T3	SecondaryOutcome 182 208	improvement of CT findings
T4	TimeFrame 209 253	at days 14 after initiation of the treatment
R1	MeasuredAt Arg1:T2 Arg2:T4	
R2	MeasuredAt Arg1:T3 Arg2:T4	
T5	OutcomeDefinition 569 659	chest CT scan was evaluated for the presence of groundglass opacities and/or consolidation
R3	DefinedAs Arg1:T3 Arg2:T5	
T6	TimeFrame 406 452	at onset of admission and 5th day of treatment
R4	MeasuredAt Arg1:T2 Arg2:T6	
T7	OutcomeDefinition 661 888	Each five lobe of the lung was assessed and the overall lung involvement was reached by summing the five lobe scores (range of possible scores, 0 â€“ 20 for each lobe and total lung involvement of possible score of 0-100 percent)
R5	DefinedAs Arg1:T3 Arg2:T7	
T8	TimeFrame 916 925	in day 14
R6	MeasuredAt Arg1:T3 Arg2:T8	
